PerturbAI

PerturbAI is an AI-native therapeutics company accelerating drug discovery through systems-level understanding of disease. Our platform integrates in vivo Perturb-seq with AI agents and models to map biological circuits directly inside intact organisms, enabling a new generation of biological model... Read more